Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Mounting Studies Link Tasigna to Arteriosclerosis, Other Dangerous Vascular Disorders

Tasigna, a medication prescribed to thousands of people to treat chronic myeloid leukemia (CML), has been linked to arteriosclerosis and other dangerous vascular disorders. These findings have led to the filing of several Tasigna lawsuits that accuse Novartis AG of … Continue reading

Second Bellwether Trial Begins in C.R. Bard IVC Filter Litigation

The second bellwether trial involving C.R. Bard Inc.’s retrievable inferior vena cava (IVC) filters got underway yesterday in the U.S. District Court, District of Arizona. Eclipse IVC Filter Fractured, Embolized in Plaintiff’s Pulmonary Artery The case selected for trial was … Continue reading

First 3M Bair Hugger Lawsuit Heads to Trial this Week in Minnesota Federal Court

A South Carolina retiree went to court in Minnesota yesterday, in a bid to obtain compensation for a debilitating joint infection he claims was caused by the 3M Company’s Bair Hugger forced air warming blanket. First Bair Hugger Lawsuit Trial … Continue reading

New Jersey Supreme Court Creates Centralized Proceeding for Abilify Gambling Lawsuits

The New Jersey Supreme Court has agreed to establish a multicounty litigation for all product liability claims filed in the state on behalf of individuals who allegedly developed gambling addictions or other impulse control disorders due to their use of … Continue reading

Few Efforts to Understand Side Effects Associated with Avelox, Other Fluoroquinolone Antibiotics.

Though Avelox and other fluoroquinolone antibiotics have been linked to thousands of adverse events, a new report suggests that doctors, pharmaceutical companies and researchers have made little effort to understand the side effects associated with these popular medications. Little Support, … Continue reading

C.R. Bard Supports MDL for Polypropylene Hernia Mesh Lawsuits – But There’s a Catch

C.R. Bard, Inc. and its Davol, Inc. subsidiary have signaled support for the establishment of a multidistrict litigation (MDL) for federally-filed product liability lawsuits involving its polypropylene hernia mesh implants, but only if the proceeding encompasses all such devices marketed … Continue reading

New Onglyza Heart Failure Lawsuits Filed in Ohio, Texas

Plaintiffs from Ohio and Texas recently joined the nationwide litigation involving the Type 2 diabetes drug Onglyza and its alleged association with heart failure. Plaintiffs Claim They Weren’t Warned of Onglyza Heart Risks According to a complaint filed in the … Continue reading

Nexium Kidney Failure Lawsuits Move Forward, as Federal Court Sets Parameters for Science Day

The federal court overseeing thousands of kidney injury lawsuits filed against the manufacturers of Nexium and other proton pump inhibitors has set parameters for Science Day, which will be convened on May 16th in the U.S. District Court, District of … Continue reading

Abilify Lawsuit Parties Given Until September to Finalize Global Settlement Agreement

The federal judge overseeing hundreds of Abilify lawsuits has issued a new Order giving the parties until September to finalize a global settlement agreement that could resolve claims involving the antipsychotic drug’s alleged potential to cause compulsive gambling and other … Continue reading

Tasigna Lawsuit News: Study Suggests Drug Company Payments May Drive Cancer Drug Prescribing

A recent study has raised concerns that drug company payments might be influencing oncologists who prescribe Tasigna and other pricey cancer drugs. How the Study Was Conducted The authors of the study, which was published this month in JAMA Internal … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content